The Spain magnetic resonance imaging market size reached USD 0.13 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 0.19 Billion by 2033, exhibiting a growth rate (CAGR) of 3.97% during 2025-2033. Rising rates of chronic diseases, an aging population, the need for non-invasive diagnostics, improvements in MRI technology, and government spending on healthcare are the main factors propelling the market growth. Market expansion is further supported by growing use of high-field MRI equipment, AI integration in imaging, and expanding private healthcare infrastructure.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 0.13 Billion |
Market Forecast in 2033 | USD 0.19 Billion |
Market Growth Rate (2025-2033) | 3.97% |
AI Integration in MRI Systems
The Spain MRI industry is experiencing significant advancements with the integration of machine learning algorithms and artificial intelligence (AI), enhancing diagnostic efficiency and accuracy. AI-powered MRI systems optimize workflows, automate anomaly detection, and accelerate image reconstruction, enabling faster and more precise diagnoses while improving overall operational efficiency in medical imaging. For instance, in May 2024, GE HealthCare announced that they are innovating MRI technology to improve diagnostic imaging, streamline workflows, and increase patient access. Its scalable solutions offer hardware upgrades for 1.5T and 3.0T systems, expanding bore size from 60cm to 70cm for enhanced patient comfort. AI-driven deep-learning reconstruction enhances image clarity and signal-to-noise ratio. The SIGNA™ Lift program provides cost-effective upgrades by utilizing existing MRI magnets. These advancements extend system longevity, minimize technology obsolescence, and improve accessibility to high-quality MRI imaging. Additionally, AI-driven post-processing techniques are enhancing the detection of complex conditions such as neurodegenerative diseases and cancer, facilitating early intervention. As AI adoption grows, Spain's radiology infrastructure is evolving, providing healthcare professionals with advanced diagnostic tools to improve patient outcomes while reducing scan times and operational costs.
Expansion of Private Healthcare and Diagnostic Imaging Centers
Spain is experiencing a rise in private healthcare investments, leading to the expansion of diagnostic imaging centers equipped with state-of-the-art MRI systems. For instance, in May 2024, the European Investment Bank (EIB) signed a €120 million loan with Castilla y León’s regional government to upgrade hospitals and healthcare facilities in Valladolid, Salamanca, Palencia, Soria, and Aranda de Duero. The financing, part of a €175 million total package, supports hospital renovations, new primary healthcare centers, and medical equipment acquisitions, benefiting 830,000 people. The growing preference for private healthcare facilities is driven by shorter wait times, better patient experience, and access to advanced imaging technologies. Private institutions are increasingly investing in open MRI systems, catering to claustrophobic and pediatric patients, and improving patient comfort. Additionally, collaborations between private healthcare providers and research institutions are fostering innovation in imaging techniques and personalized diagnostics. The expansion of diagnostic imaging centers is also addressing the increasing demand for early disease detection and preventive healthcare, supporting the broader adoption of MRI technology in oncology, cardiology, and orthopedics.
Innovations in Contrast Agents
The Spain MRI market is advancing with innovations in contrast agents, driven by safety concerns and environmental impact. For instance, GE HealthCare's Phase I trial of a manganese-based macrocyclic MRI contrast agent in October 2024 demonstrated strong safety and tolerability, addressing the risks associated with gadolinium-based agents. As Spain continues to adopt safer and sustainable healthcare solutions, the shift towards manganese-based contrast agents is expected to drive demand for MRI procedures. Regulatory bodies and healthcare institutions in Spain are likely to promote the adoption of non-toxic alternatives, supporting market growth. Additionally, advancements in MRI technology, including AI-enhanced imaging and improved contrast agents, are contributing to increased diagnostic accuracy and efficiency, further boosting the MRI market in Spain.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on architecture, field strength, application, and end use.
Architecture Insights:
A detailed breakup and analysis of the market based on the architecture have been provided in the report. This includes closed and open system.
Field Strength Insights:
A detailed breakup and analysis of the market based on the field strength have also been provided in the report. This includes low field strength, mid field strength, and high field strength.
Application Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes obstructive sleep apnea (OSA), brain and neurological, spine and musculoskeletal, vascular, abdominal, cardiac, breast, and others.
End Use Insights:
A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes hospitals, imaging centers, ambulatory surgical centers, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern, Eastern, Southern, and Central Spain.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Architectures Covered | Closed System, Open System |
Field Strengths Covered | Low Field Strength, Mid Field Strength, High Field Strength. |
Applications Covered | Obstructive Sleep Apnea (OSA), Brain and Neurological, Spine and Musculoskeletal, Vascular, Abdominal, Cardiac, Breast, Others |
End Uses Covered | Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others |
Regions Covered | Northern Spain, Eastern Spain, Southern Spain, Central Spain |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: